Interferon β and Anti-PD-1/PD-L1 Checkpoint Blockade Cooperate in NK Cell-Mediated Killing of Nasopharyngeal Carcinoma Cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Translational oncology 12(9), Seiten/Artikel-Nr.:1237-1256
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2019
- Creator
-
Makowska, Anna
Braunschweig, Till
Denecke, Bernd
Shen, Lian
Baloche, Valentin
Busson, Pierre
Kontny, Udo
- DOI
-
10.1016/j.tranon.2019.04.017
- URN
-
urn:nbn:de:101:1-2020102806222183373494
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:47 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Makowska, Anna
- Braunschweig, Till
- Denecke, Bernd
- Shen, Lian
- Baloche, Valentin
- Busson, Pierre
- Kontny, Udo
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2019
Other Objects (12)
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Anti-PD-1 antibody increases NK cell cytotoxicity towards nasopharyngeal carcinoma cells in the context of chemotherapy-induced upregulation of PD-1 and PD-L1
The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Expression von PD-L1 und PD-1 im nicht-kleinzelligen Lungenkarzinom
Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
New first line treatment options of clear cell renal cell cancer patients with PD-1 or PD-L1 immune-checkpoint inhibitor-based combination therapies
Prognostic value of immunohistochemical expression of PD-1 and PD-L1 on tumor cells and tumor-infiltrating stromal immune cells in primary breast cancer
Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas
Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Anti-PD-1 antibody increases NK cell cytotoxicity towards nasopharyngeal carcinoma cells in the context of chemotherapy-induced upregulation of PD-1 and PD-L1
The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Expression von PD-L1 und PD-1 im nicht-kleinzelligen Lungenkarzinom
Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
New first line treatment options of clear cell renal cell cancer patients with PD-1 or PD-L1 immune-checkpoint inhibitor-based combination therapies
Prognostic value of immunohistochemical expression of PD-1 and PD-L1 on tumor cells and tumor-infiltrating stromal immune cells in primary breast cancer
Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas
Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Anti-PD-1 antibody increases NK cell cytotoxicity towards nasopharyngeal carcinoma cells in the context of chemotherapy-induced upregulation of PD-1 and PD-L1
The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Expression von PD-L1 und PD-1 im nicht-kleinzelligen Lungenkarzinom
Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
New first line treatment options of clear cell renal cell cancer patients with PD-1 or PD-L1 immune-checkpoint inhibitor-based combination therapies
Prognostic value of immunohistochemical expression of PD-1 and PD-L1 on tumor cells and tumor-infiltrating stromal immune cells in primary breast cancer
Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas
Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom